Prestige News

Total 78
Number Thumbnail Title Author Date Votes Views
78 Prestige Biopharma IDC's Taeheung Kang, Director of Drug Development Division: 'Additional Pipelines Ready… Accelerating Resear
김** | 2026.10.01 | Votes 0 | Views 274
김** 2026.10.01 0 274
77 Prestige Biopharma Appoints Neil O’Connor as Board Director, Strengthening Expertise in CMC and Quality Management
김** | 2026.09.30 | Votes 0 | Views 236
김** 2026.09.30 0 236
76 Prestige Biopharma Receives Brazilian Marketing Authorization for Herceptin Biosimilar Tuznue
김** | 2026.09.28 | Votes 0 | Views 474
김** 2026.09.28 0 474
75 Prestige Biopharma’s Tuznue Receives Marketing Authorization in Trinidad and Tobago
김** | 2026.09.18 | Votes 0 | Views 727
김** 2026.09.18 0 727
74 Prestige Biopharma IDC Obtains ISO 14001 and ISO 45001 Certifications
김** | 2026.09.17 | Votes 0 | Views 519
김** 2026.09.17 0 519
73 Prestige Biopharma Successfully Concludes ‘Prestige Symposium’ on Aging
김** | 2026.09.09 | Votes 0 | Views 1119
김** 2026.09.09 0 1119
72 Prestige Biopharma IDC CEO Ko Sang-seok Purchases Company Shares on the Open Market
김** | 2026.09.03 | Votes 0 | Views 1346
김** 2026.09.03 0 1346
71 Prestige Biopharma’s Tuznue Secures Brazilian GMP Certification, Supporting Latin American Approval Process
김** | 2026.08.25 | Votes 0 | Views 2013
김** 2026.08.25 0 2013
70 Prestige Biopharma Files Patent Application for TASA™, a Blood-Based Pancreatic Cancer Diagnostic Platform
김** | 2026.08.12 | Votes 0 | Views 2033
김** 2026.08.12 0 2033
69 Prestige Biopharma Positions PBP1710 as Its Next-Generation Growth Driver
김** | 2026.08.11 | Votes 0 | Views 2561
김** 2026.08.11 0 2561